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Until recently quinine was the only drug employed in the treatment of all forms of malaria, but Acton (1920) showed that, while it cured 90 per cent of malignant tertian infections if properly given, in benign tertian infections the primary cures were not more than 25 to 30 per cent even after a two months' course.
Cinchona febrifuge which contains all the alkaloids of cinchona bark gave a cure rate of about 50 per cent so that it could be reasonably concluded that there must be alkaloids other than quinine which are responsible for this enhanced rate of cure. These other alkaloids were tested by him individually. Cinchonine and quinidine in 10-grain doses twice daily gave a cure rate of 60 per cent of benign tertian infection after a short course. Fletcher (1923) [Aug., 1934 In every case the parasites, except the crescents, disappeared from the blood within four days. Of Certain untoward symptoms were met with during the treatment with Malarcan which, however, were not serious. Cases 2G and 28 had a reeling sensation which gradually disappeared when the drug was stopped. In two patients flatulence, abdominal discomfort and insomnia developed, but they were temporary and were got rid of with a dose of carminative or a bromide mixture.
Summary and conclusion
(1) Malarcan is said to be a compound of a stereo-isomeric base of methyl-cupreine combined with methyl-acridinium-chloride and hydrocholic acid. It is probably a derivative of quinine or quinidine.
(2) The effect of Malarcan on Indian strains of malaria closely resembles that of quinine. Its action on the asexual forms of malignant tertian is rapid, while on the crescents it has no action whatsoever. On the sexual and asexual forms of benign tertian and quartan the drug has an action similar to that of quinine.
(3) The action of the drug on relapses is also very similar to that of quinine.
(Continued, at foot of next column) (Continued from previous column) (4) Malarcan is not a toxic drug and in the doses recommended by the makers it produced no serious untoward symptoms.
(5) The drug is about 4 to 5 times more expensive than quinine and appears to have no advantage over that drug.
